Amyloidosis is characterized by the extracellular deposition of amyloid in various tissues and organs, particularly the kidney and heart. The estimated incidence of systemic amyloidosis is at least 8 per million population per year. However, few cases of systemic amyloidosis in renal allografts have been reported. A stable renal transplant recipient was admitted with proteinuria and dyspnea on exertion. The M-peak was found on serum and urine protein electrophoresis, and lambda (λ) dominance was confirmed by serum and urine free-light-chain test. The patient was diagnosed with systemic amyloidosis of a renal allograft, by allograft biopsy, at 22 years after renal transplantation. We report a case of AL amyloidosis in a stable renal allograft and review the medical literature. 
(D) Electron micrograph shows widened mesangium due to non-branching long amyloid fibrils without mesangial cellular proliferation. The GBM is partially thickened due to these fibrils (×4,000). GBM, glomerular basement membrane. TnT, troponin-T; CK-MB, creatine kinase-isoenzyme MB. 
